Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ng

Showing results (111-120 of 287) with videos related to

Pageof 29
Sort By:
Radiation Research|March 1, 1994
Comparison of thermoradiosensitization in two human melanoma cell lines and one fibroblast cell line by concurrent mild hyperthermia and low-dose-rate irradiationG P Raaphorst, A Bussey, D P Heller, et al.
Psychoneuroendocrinology|August 8, 2024
Affect regulation and allostatic load over timeAmanda E Ng, Tara Gruenewald, Robert-Paul Juster, et al.
Anticancer Research|August 11, 2001
The response of human breast tumour cell lines with altered polymerase beta levels to cisplatin and radiationG P Raaphorst, S E Cybulski, R Sobol, et al.
Journal of Biological Response Modifiers|February 1, 1990
Synergistic actions of picibanil (OK-432) on recombinant interleukin-2 induction of tumor-infiltrating lymphocyte expansion, cytotoxicity, and phenotypic differentiationR Lafreniere, K Borkenhagen, L D Bryant, et al.
International Journal of Cancer|May 16, 2009
APM2 is a novel mediator of cisplatin resistance in a variety of cancer cell types regardless of p53 or MMR statusBradley J Scott, Sami Qutob, Qing Y Liu, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|November 1, 1996
Cisplatin, hyperthermia and radiation treatment in human cisplatin-sensitive and resistant glioma cell linesG P Raaphorst, H Yang, D E Wilkins, et al.
Annals of the Academy of Medicine, Singapore|March 12, 2002
Osteoporosis: a treatable diseaseK H Leong, L K H Koh, D C E Ng
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|March 1, 1994
Thermal radiosensitization by 41 degrees C hyperthermia during low dose-rate irradiation in human normal and tumour cell linesG P Raaphorst, D P Heller, A Bussey, et al.
ANZ Journal of Surgery|March 8, 2018
True left-sided gallbladder: a rare anatomical anomaly and its associated surgical challengesGaik Si Quah, Ian E Ng, Gratian Punch, et al.
Oncology Reports|June 19, 1998
Concomitant treatment with mild hyperthermia, cisplatin and low dose-rate irradiation in human ovarian cancer cells sensitive and resistant to cisplatinG P Raaphorst, J Maio, C E Ng, et al.
Pageof 29

Showing results (111-120 of 287) with videos related to

Sort By:
Pageof 29
Radiation Research|March 1, 1994
Comparison of thermoradiosensitization in two human melanoma cell lines and one fibroblast cell line by concurrent mild hyperthermia and low-dose-rate irradiationG P Raaphorst, A Bussey, D P Heller, et al.
Psychoneuroendocrinology|August 8, 2024
Affect regulation and allostatic load over timeAmanda E Ng, Tara Gruenewald, Robert-Paul Juster, et al.
Anticancer Research|August 11, 2001
The response of human breast tumour cell lines with altered polymerase beta levels to cisplatin and radiationG P Raaphorst, S E Cybulski, R Sobol, et al.
Journal of Biological Response Modifiers|February 1, 1990
Synergistic actions of picibanil (OK-432) on recombinant interleukin-2 induction of tumor-infiltrating lymphocyte expansion, cytotoxicity, and phenotypic differentiationR Lafreniere, K Borkenhagen, L D Bryant, et al.
International Journal of Cancer|May 16, 2009
APM2 is a novel mediator of cisplatin resistance in a variety of cancer cell types regardless of p53 or MMR statusBradley J Scott, Sami Qutob, Qing Y Liu, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|November 1, 1996
Cisplatin, hyperthermia and radiation treatment in human cisplatin-sensitive and resistant glioma cell linesG P Raaphorst, H Yang, D E Wilkins, et al.
Annals of the Academy of Medicine, Singapore|March 12, 2002
Osteoporosis: a treatable diseaseK H Leong, L K H Koh, D C E Ng
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|March 1, 1994
Thermal radiosensitization by 41 degrees C hyperthermia during low dose-rate irradiation in human normal and tumour cell linesG P Raaphorst, D P Heller, A Bussey, et al.
ANZ Journal of Surgery|March 8, 2018
True left-sided gallbladder: a rare anatomical anomaly and its associated surgical challengesGaik Si Quah, Ian E Ng, Gratian Punch, et al.
Oncology Reports|June 19, 1998
Concomitant treatment with mild hyperthermia, cisplatin and low dose-rate irradiation in human ovarian cancer cells sensitive and resistant to cisplatinG P Raaphorst, J Maio, C E Ng, et al.
Pageof 29